Getinge announced today that it expanded its Servo-c ventilator offerings with a neonatal option to support all patient categories.
The extension means the company offers a universal respiratory care solution for all. It now ranges from fragile, premature newborns to fully grown adults.
“Hospitals are under increasing pressure to deliver high-quality care for diverse patient needs while managing costs. Servo-c now supports this by enabling personalized respiratory treatment across all patient categories – from premature newborns to full-grown adults – with full flexibility in targeted markets,” said Cecilia Sjöstedt, VP, Critical Care at Getinge. “This is part of our commitment to make life-saving technology accessible for more people.”
Getinge said it designed its new neonatal option to support premature-born babies weighing as little as 500 grams. It also eliminates the requirement for additional physical accessories accompanying the ventilator.
Additionally, Gentinge says its Servo-c neonatal option offers invasive leakage compensation. It also complies with the latest international standards for product safety, biocompatibility, and cybersecurity.
“Since our first Servo ventilator was introduced over 50 years ago, our focus has been on continuous innovation, better outcomes, increased patient safety and outstanding user experience. We are proud of our legacy and remain committed to leading the way in developing ventilators for the future,” Sjöstedt says.
